Stada and Xbrane gain EU approval for biosimilar Ximluci
Partnership combines Xbrane’s protein-expression system with Stada’s management teams
Read More
Tag: ximluci
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
